The heterozygote state for β‐thalassemia detrimentally affects health outcomes-Reference-Cited by-同舟云学术

The heterozygote state for β‐thalassemia detrimentally affects health outcomes

Published:2017-02 Issue:3 Volume:92 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Graffeo Luciano¹,Vitrano Angela¹,Giambona Antonino¹,Scondotto Salvatore²,Dardanoni Gabriella²,Gluud Christian³,Maggio Aurelio¹

Affiliation:

1. Campus of Hematology Franco e Piera Cutino, AOOR Villa Sofia‐V. CervelloPalermo Italy

2. Dipartimento Attività Sanitarie e Osservatorio Epidemiologico Assessorato Salute Regione SiciliaPalermo Italy

3. The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, RigshospitaletCopenhagen University HospitalCopenhagen Denmark

Funder

Foundation Franco and Piera Cutino

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.24619

Reference8 articles.

1. Incidence of haemoglobinopathies in Sicily: the impact of screening and prenatal diagnosis

2. Organizzazione Mondiale della Sanità.ICD‐10 International Classification of Diseases. 9thRevision Clinical Modification. Roma Italy: Istituto Poligrafico e Zecca dello Stato;1997.

3. Average life expectancy of heterozygous beta thalassemic subjects;Gallerani M;Haematologica.,1990

4. Haemochromatosis in patients with β-thalassaemia trait

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCL11A Polymorphism in Egyptian Children with β-Thalassemia: Relation to Phenotypic Heterogeneity;Journal of Pediatric Genetics;2021-06-01

2. α, β, δ and γ thalassaemias and related conditions;Haemoglobinopathy Diagnosis;2020-02-28

3. HbA1C as a marker of retrograde glycaemic control in diabetes patient with co‐existed beta‐thalassaemia: A case report and a literature review;Journal of Clinical Pharmacy and Therapeutics;2019-11-17

4. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice;Experimental Hematology;2018-08